Related Experiment Video
Updated: Jul 8, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Bleeding during percutaneous intervention: tailoring the approach to minimise risk
T Kinnaird1, R Anderson, J Hill
1Department of Cardiology, University Hospital of Wales, Heath Park, Cardiff, UK. tim.kinnaird@cardiffandvale.wales.nhs.uk
Bleeding is now a leading complication of percutaneous coronary intervention (PCI), often increased by treatments meant to prevent clots. This review highlights bleeding risks and proposes strategies to minimize their occurrence during PCI.
Area of Science:
- Cardiology
- Interventional Cardiology
- Patient Safety
Background:
- Ischemic complications during percutaneous coronary intervention (PCI) have decreased.
- Bleeding has become a primary complication following PCI.
- Treatments to reduce ischemic events may paradoxically increase bleeding risk.
Purpose of the Study:
- To review current data on bleeding complications after PCI.
- To emphasize the significant impact of bleeding on patient mortality.
- To propose strategies for minimizing bleeding during PCI.
Main Methods:
- Conducted a PubMed search using terms "bleeding" and "percutaneous coronary intervention".
- Summarized major trial and registry data.
- Synthesized findings to propose preventative strategies.
Main Results:
- Bleeding is a common and significant complication of contemporary PCI.
- Major bleeding is associated with increased mortality.
- Interventions aimed at reducing ischemia may exacerbate bleeding.
Conclusions:
- Bleeding following PCI requires proactive management, not just transfusion.
- Minimizing bleeding is crucial for improving patient outcomes after PCI.
- Evidence-based strategies can effectively reduce bleeding incidence.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins

